Key Insight: Extinguisher Presence Does Not Equal Extinguisher Readiness Over 5,000 workplace fires occur annually in the US according to OSHA reporting data, resulting in millions of dollars in property damage and significant injury risk. Yet a recu
Cranes are among the most dangerous pieces of equipment on any job site, and field service cranes carry a specific set of risks that fixed installations do not. They move between sites, operate in uncontrolled ground conditions, and are assembled
989inspections conducted FY2024+27%increase vs FY202362%foreign site inspections (all-time high)105drug warning letters (5-year high) FDA Form 483 data is one of the clearest windows available into where quality systems actually fail, not where com
Key Insight CAPA remains the number one cited observation by the FDA for 2024 among companies that received an official action indicated (OAI) designation from inspections, according to Keisha Thomas of the FDA speaking at the FDLI Enforcement, Litig
Key Insight Annex 11 of the EU GMP guidelines, the document that governs how pharmaceutical manufacturers must design, validate, and operate computerised systems, has gone largely unchanged since 2011. On 7 July 2025, the European Commission and the
A calibration program represents far more than a routine maintenance exercise. It is a strategic framework that ensures measurement accuracy, maintains regulatory compliance, prevents product defects, and protects organizational reputation. For
Insights • Worker Safety (USA) Clear leadership, faster evacuations, and stronger OSHA-aligned Emergency Action Plans in offices, hospitals, and apartments. Read time: 7 minutes Supports OSHA 29 CFR 1910.38 (EAP) Table of Contents In
Clear plans save lives, support OSHA compliance, and build a calm, safety-first culture. ⏱️ Read time: ~6 min • Table of Contents Introduction OSHA and Compliance Context
Prescription stimulants are widely used in the United States for conditions such as ADHD and narcolepsy. However, in recent years, these medications have moved beyond medical necessity and into the realm of misuse. This trend has not only raised publ
Bringing a new drug to market in the United States is one of the toughest regulatory journeys in the world. The U.S. Food and Drug Administration (FDA) closely examines every submission, and many applications face rejection, delay, or multiple rounds
